Firms Push for Over-the-Counter Access to Birth-Control Pills
Two drug makers have been mired for years in the pre-application phase of getting F.D.A. approval for over-the-counter use.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.